This report aims to provide a comprehensive presentation of the global market for AI Pharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Pharma. This report contains market size and forecasts of AI Pharma in global, including the following market information:
Global AI Pharma Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global AI Pharma market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Self-developed Oipeline Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of AI Pharma include Recursion, Insilico Medicine, Exscientia, BenevolentAI, Atomwise, Roivant Sciences, Schr?dinger, Lantern Pharma and XtalPi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the AI Pharma companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global AI Pharma Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global AI Pharma Market Segment Percentages, by Type, 2022 (%)
Self-developed Oipeline
Contract Research Organization (CRO)
Other
Global AI Pharma Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global AI Pharma Market Segment Percentages, by Application, 2022 (%)
Preclinical Stage (Optimization of Lead Compounds, etc.)
Clinical Trial Phase (Predicting Treatment Outcome, etc.)
Global AI Pharma Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global AI Pharma Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies AI Pharma revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies AI Pharma revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Recursion
Insilico Medicine
Exscientia
BenevolentAI
Atomwise
Roivant Sciences
Schr?dinger
Lantern Pharma
XtalPi
Landos Biopharma
Relay Therapeutics
Accutar Biotech
Deep Genomics
Oncocross
AI Therapeutics
BioMap
METiS Pharmaceuticals
NeoX Biotech
StoneWise
Deep Intelligent Pharma
Gigaceuticals
Chemical.AI
Artivila
Galixir
Xbiome
Outline of Major Chapters:
Chapter 1: Introduces the definition of AI Pharma, market overview.
Chapter 2: Global AI Pharma market size in revenue.
Chapter 3: Detailed analysis of AI Pharma company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of AI Pharma in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 AI Pharma Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global AI Pharma Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global AI Pharma Overall Market Size
2.1 Global AI Pharma Market Size: 2022 VS 2030
2.2 Global AI Pharma Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top AI Pharma Players in Global Market
3.2 Top Global AI Pharma Companies Ranked by Revenue
3.3 Global AI Pharma Revenue by Companies
3.4 Top 3 and Top 5 AI Pharma Companies in Global Market, by Revenue in 2022
3.5 Global Companies AI Pharma Product Type
3.6 Tier 1, Tier 2 and Tier 3 AI Pharma Players in Global Market
3.6.1 List of Global Tier 1 AI Pharma Companies
3.6.2 List of Global Tier 2 and Tier 3 AI Pharma Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global AI Pharma Market Size Markets, 2022 & 2030
4.1.2 Self-developed Oipeline
4.1.3 Contract Research Organization (CRO)
4.1.4 Other
4.2 By Type - Global AI Pharma Revenue & Forecasts
4.2.1 By Type - Global AI Pharma Revenue, 2018-2023
4.2.2 By Type - Global AI Pharma Revenue, 2024-2030
4.2.3 By Type - Global AI Pharma Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global AI Pharma Market Size, 2022 & 2030
5.1.2 Preclinical Stage (Optimization of Lead Compounds, etc.)
5.1.3 Clinical Trial Phase (Predicting Treatment Outcome, etc.)
5.2 By Application - Global AI Pharma Revenue & Forecasts
5.2.1 By Application - Global AI Pharma Revenue, 2018-2023
5.2.2 By Application - Global AI Pharma Revenue, 2024-2030
5.2.3 By Application - Global AI Pharma Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global AI Pharma Market Size, 2022 & 2030
6.2 By Region - Global AI Pharma Revenue & Forecasts
6.2.1 By Region - Global AI Pharma Revenue, 2018-2023
6.2.2 By Region - Global AI Pharma Revenue, 2024-2030
6.2.3 By Region - Global AI Pharma Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America AI Pharma Revenue, 2018-2030
6.3.2 US AI Pharma Market Size, 2018-2030
6.3.3 Canada AI Pharma Market Size, 2018-2030
6.3.4 Mexico AI Pharma Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe AI Pharma Revenue, 2018-2030
6.4.2 Germany AI Pharma Market Size, 2018-2030
6.4.3 France AI Pharma Market Size, 2018-2030
6.4.4 U.K. AI Pharma Market Size, 2018-2030
6.4.5 Italy AI Pharma Market Size, 2018-2030
6.4.6 Russia AI Pharma Market Size, 2018-2030
6.4.7 Nordic Countries AI Pharma Market Size, 2018-2030
6.4.8 Benelux AI Pharma Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia AI Pharma Revenue, 2018-2030
6.5.2 China AI Pharma Market Size, 2018-2030
6.5.3 Japan AI Pharma Market Size, 2018-2030
6.5.4 South Korea AI Pharma Market Size, 2018-2030
6.5.5 Southeast Asia AI Pharma Market Size, 2018-2030
6.5.6 India AI Pharma Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America AI Pharma Revenue, 2018-2030
6.6.2 Brazil AI Pharma Market Size, 2018-2030
6.6.3 Argentina AI Pharma Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa AI Pharma Revenue, 2018-2030
6.7.2 Turkey AI Pharma Market Size, 2018-2030
6.7.3 Israel AI Pharma Market Size, 2018-2030
6.7.4 Saudi Arabia AI Pharma Market Size, 2018-2030
6.7.5 UAE AI Pharma Market Size, 2018-2030
7 AI Pharma Companies Profiles
7.1 Recursion
7.1.1 Recursion Company Summary
7.1.2 Recursion Business Overview
7.1.3 Recursion AI Pharma Major Product Offerings
7.1.4 Recursion AI Pharma Revenue in Global Market (2018-2023)
7.1.5 Recursion Key News & Latest Developments
7.2 Insilico Medicine
7.2.1 Insilico Medicine Company Summary
7.2.2 Insilico Medicine Business Overview
7.2.3 Insilico Medicine AI Pharma Major Product Offerings
7.2.4 Insilico Medicine AI Pharma Revenue in Global Market (2018-2023)
7.2.5 Insilico Medicine Key News & Latest Developments
7.3 Exscientia
7.3.1 Exscientia Company Summary
7.3.2 Exscientia Business Overview
7.3.3 Exscientia AI Pharma Major Product Offerings
7.3.4 Exscientia AI Pharma Revenue in Global Market (2018-2023)
7.3.5 Exscientia Key News & Latest Developments
7.4 BenevolentAI
7.4.1 BenevolentAI Company Summary
7.4.2 BenevolentAI Business Overview
7.4.3 BenevolentAI AI Pharma Major Product Offerings
7.4.4 BenevolentAI AI Pharma Revenue in Global Market (2018-2023)
7.4.5 BenevolentAI Key News & Latest Developments
7.5 Atomwise
7.5.1 Atomwise Company Summary
7.5.2 Atomwise Business Overview
7.5.3 Atomwise AI Pharma Major Product Offerings
7.5.4 Atomwise AI Pharma Revenue in Global Market (2018-2023)
7.5.5 Atomwise Key News & Latest Developments
7.6 Roivant Sciences
7.6.1 Roivant Sciences Company Summary
7.6.2 Roivant Sciences Business Overview
7.6.3 Roivant Sciences AI Pharma Major Product Offerings
7.6.4 Roivant Sciences AI Pharma Revenue in Global Market (2018-2023)
7.6.5 Roivant Sciences Key News & Latest Developments
7.7 Schr?dinger
7.7.1 Schr?dinger Company Summary
7.7.2 Schr?dinger Business Overview
7.7.3 Schr?dinger AI Pharma Major Product Offerings
7.7.4 Schr?dinger AI Pharma Revenue in Global Market (2018-2023)
7.7.5 Schr?dinger Key News & Latest Developments
7.8 Lantern Pharma
7.8.1 Lantern Pharma Company Summary
7.8.2 Lantern Pharma Business Overview
7.8.3 Lantern Pharma AI Pharma Major Product Offerings
7.8.4 Lantern Pharma AI Pharma Revenue in Global Market (2018-2023)
7.8.5 Lantern Pharma Key News & Latest Developments
7.9 XtalPi
7.9.1 XtalPi Company Summary
7.9.2 XtalPi Business Overview
7.9.3 XtalPi AI Pharma Major Product Offerings
7.9.4 XtalPi AI Pharma Revenue in Global Market (2018-2023)
7.9.5 XtalPi Key News & Latest Developments
7.10 Landos Biopharma
7.10.1 Landos Biopharma Company Summary
7.10.2 Landos Biopharma Business Overview
7.10.3 Landos Biopharma AI Pharma Major Product Offerings
7.10.4 Landos Biopharma AI Pharma Revenue in Global Market (2018-2023)
7.10.5 Landos Biopharma Key News & Latest Developments
7.11 Relay Therapeutics
7.11.1 Relay Therapeutics Company Summary
7.11.2 Relay Therapeutics Business Overview
7.11.3 Relay Therapeutics AI Pharma Major Product Offerings
7.11.4 Relay Therapeutics AI Pharma Revenue in Global Market (2018-2023)
7.11.5 Relay Therapeutics Key News & Latest Developments
7.12 Accutar Biotech
7.12.1 Accutar Biotech Company Summary
7.12.2 Accutar Biotech Business Overview
7.12.3 Accutar Biotech AI Pharma Major Product Offerings
7.12.4 Accutar Biotech AI Pharma Revenue in Global Market (2018-2023)
7.12.5 Accutar Biotech Key News & Latest Developments
7.13 Deep Genomics
7.13.1 Deep Genomics Company Summary
7.13.2 Deep Genomics Business Overview
7.13.3 Deep Genomics AI Pharma Major Product Offerings
7.13.4 Deep Genomics AI Pharma Revenue in Global Market (2018-2023)
7.13.5 Deep Genomics Key News & Latest Developments
7.14 Oncocross
7.14.1 Oncocross Company Summary
7.14.2 Oncocross Business Overview
7.14.3 Oncocross AI Pharma Major Product Offerings
7.14.4 Oncocross AI Pharma Revenue in Global Market (2018-2023)
7.14.5 Oncocross Key News & Latest Developments
7.15 AI Therapeutics
7.15.1 AI Therapeutics Company Summary
7.15.2 AI Therapeutics Business Overview
7.15.3 AI Therapeutics AI Pharma Major Product Offerings
7.15.4 AI Therapeutics AI Pharma Revenue in Global Market (2018-2023)
7.15.5 AI Therapeutics Key News & Latest Developments
7.16 BioMap
7.16.1 BioMap Company Summary
7.16.2 BioMap Business Overview
7.16.3 BioMap AI Pharma Major Product Offerings
7.16.4 BioMap AI Pharma Revenue in Global Market (2018-2023)
7.16.5 BioMap Key News & Latest Developments
7.17 METiS Pharmaceuticals
7.17.1 METiS Pharmaceuticals Company Summary
7.17.2 METiS Pharmaceuticals Business Overview
7.17.3 METiS Pharmaceuticals AI Pharma Major Product Offerings
7.17.4 METiS Pharmaceuticals AI Pharma Revenue in Global Market (2018-2023)
7.17.5 METiS Pharmaceuticals Key News & Latest Developments
7.18 NeoX Biotech
7.18.1 NeoX Biotech Company Summary
7.18.2 NeoX Biotech Business Overview
7.18.3 NeoX Biotech AI Pharma Major Product Offerings
7.18.4 NeoX Biotech AI Pharma Revenue in Global Market (2018-2023)
7.18.5 NeoX Biotech Key News & Latest Developments
7.19 StoneWise
7.19.1 StoneWise Company Summary
7.19.2 StoneWise Business Overview
7.19.3 StoneWise AI Pharma Major Product Offerings
7.19.4 StoneWise AI Pharma Revenue in Global Market (2018-2023)
7.19.5 StoneWise Key News & Latest Developments
7.20 Deep Intelligent Pharma
7.20.1 Deep Intelligent Pharma Company Summary
7.20.2 Deep Intelligent Pharma Business Overview
7.20.3 Deep Intelligent Pharma AI Pharma Major Product Offerings
7.20.4 Deep Intelligent Pharma AI Pharma Revenue in Global Market (2018-2023)
7.20.5 Deep Intelligent Pharma Key News & Latest Developments
7.21 Gigaceuticals
7.21.1 Gigaceuticals Company Summary
7.21.2 Gigaceuticals Business Overview
7.21.3 Gigaceuticals AI Pharma Major Product Offerings
7.21.4 Gigaceuticals AI Pharma Revenue in Global Market (2018-2023)
7.21.5 Gigaceuticals Key News & Latest Developments
7.22 Chemical.AI
7.22.1 Chemical.AI Company Summary
7.22.2 Chemical.AI Business Overview
7.22.3 Chemical.AI AI Pharma Major Product Offerings
7.22.4 Chemical.AI AI Pharma Revenue in Global Market (2018-2023)
7.22.5 Chemical.AI Key News & Latest Developments
7.23 Artivila
7.23.1 Artivila Company Summary
7.23.2 Artivila Business Overview
7.23.3 Artivila AI Pharma Major Product Offerings
7.23.4 Artivila AI Pharma Revenue in Global Market (2018-2023)
7.23.5 Artivila Key News & Latest Developments
7.24 Galixir
7.24.1 Galixir Company Summary
7.24.2 Galixir Business Overview
7.24.3 Galixir AI Pharma Major Product Offerings
7.24.4 Galixir AI Pharma Revenue in Global Market (2018-2023)
7.24.5 Galixir Key News & Latest Developments
7.25 Xbiome
7.25.1 Xbiome Company Summary
7.25.2 Xbiome Business Overview
7.25.3 Xbiome AI Pharma Major Product Offerings
7.25.4 Xbiome AI Pharma Revenue in Global Market (2018-2023)
7.25.5 Xbiome Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. AI Pharma Market Opportunities & Trends in Global Market
Table 2. AI Pharma Market Drivers in Global Market
Table 3. AI Pharma Market Restraints in Global Market
Table 4. Key Players of AI Pharma in Global Market
Table 5. Top AI Pharma Players in Global Market, Ranking by Revenue (2022)
Table 6. Global AI Pharma Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global AI Pharma Revenue Share by Companies, 2018-2023
Table 8. Global Companies AI Pharma Product Type
Table 9. List of Global Tier 1 AI Pharma Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 AI Pharma Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global AI Pharma Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - AI Pharma Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - AI Pharma Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global AI Pharma Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - AI Pharma Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - AI Pharma Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global AI Pharma Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global AI Pharma Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global AI Pharma Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America AI Pharma Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America AI Pharma Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe AI Pharma Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe AI Pharma Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia AI Pharma Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia AI Pharma Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America AI Pharma Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America AI Pharma Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa AI Pharma Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa AI Pharma Revenue, (US$, Mn), 2024-2030
Table 30. Recursion Company Summary
Table 31. Recursion AI Pharma Product Offerings
Table 32. Recursion AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 33. Recursion Key News & Latest Developments
Table 34. Insilico Medicine Company Summary
Table 35. Insilico Medicine AI Pharma Product Offerings
Table 36. Insilico Medicine AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 37. Insilico Medicine Key News & Latest Developments
Table 38. Exscientia Company Summary
Table 39. Exscientia AI Pharma Product Offerings
Table 40. Exscientia AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 41. Exscientia Key News & Latest Developments
Table 42. BenevolentAI Company Summary
Table 43. BenevolentAI AI Pharma Product Offerings
Table 44. BenevolentAI AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 45. BenevolentAI Key News & Latest Developments
Table 46. Atomwise Company Summary
Table 47. Atomwise AI Pharma Product Offerings
Table 48. Atomwise AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 49. Atomwise Key News & Latest Developments
Table 50. Roivant Sciences Company Summary
Table 51. Roivant Sciences AI Pharma Product Offerings
Table 52. Roivant Sciences AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 53. Roivant Sciences Key News & Latest Developments
Table 54. Schr?dinger Company Summary
Table 55. Schr?dinger AI Pharma Product Offerings
Table 56. Schr?dinger AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 57. Schr?dinger Key News & Latest Developments
Table 58. Lantern Pharma Company Summary
Table 59. Lantern Pharma AI Pharma Product Offerings
Table 60. Lantern Pharma AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 61. Lantern Pharma Key News & Latest Developments
Table 62. XtalPi Company Summary
Table 63. XtalPi AI Pharma Product Offerings
Table 64. XtalPi AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 65. XtalPi Key News & Latest Developments
Table 66. Landos Biopharma Company Summary
Table 67. Landos Biopharma AI Pharma Product Offerings
Table 68. Landos Biopharma AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 69. Landos Biopharma Key News & Latest Developments
Table 70. Relay Therapeutics Company Summary
Table 71. Relay Therapeutics AI Pharma Product Offerings
Table 72. Relay Therapeutics AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 73. Relay Therapeutics Key News & Latest Developments
Table 74. Accutar Biotech Company Summary
Table 75. Accutar Biotech AI Pharma Product Offerings
Table 76. Accutar Biotech AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 77. Accutar Biotech Key News & Latest Developments
Table 78. Deep Genomics Company Summary
Table 79. Deep Genomics AI Pharma Product Offerings
Table 80. Deep Genomics AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 81. Deep Genomics Key News & Latest Developments
Table 82. Oncocross Company Summary
Table 83. Oncocross AI Pharma Product Offerings
Table 84. Oncocross AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 85. Oncocross Key News & Latest Developments
Table 86. AI Therapeutics Company Summary
Table 87. AI Therapeutics AI Pharma Product Offerings
Table 88. AI Therapeutics AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 89. AI Therapeutics Key News & Latest Developments
Table 90. BioMap Company Summary
Table 91. BioMap AI Pharma Product Offerings
Table 92. BioMap AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 93. BioMap Key News & Latest Developments
Table 94. METiS Pharmaceuticals Company Summary
Table 95. METiS Pharmaceuticals AI Pharma Product Offerings
Table 96. METiS Pharmaceuticals AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 97. METiS Pharmaceuticals Key News & Latest Developments
Table 98. NeoX Biotech Company Summary
Table 99. NeoX Biotech AI Pharma Product Offerings
Table 100. NeoX Biotech AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 101. NeoX Biotech Key News & Latest Developments
Table 102. StoneWise Company Summary
Table 103. StoneWise AI Pharma Product Offerings
Table 104. StoneWise AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 105. StoneWise Key News & Latest Developments
Table 106. Deep Intelligent Pharma Company Summary
Table 107. Deep Intelligent Pharma AI Pharma Product Offerings
Table 108. Deep Intelligent Pharma AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 109. Deep Intelligent Pharma Key News & Latest Developments
Table 110. Gigaceuticals Company Summary
Table 111. Gigaceuticals AI Pharma Product Offerings
Table 112. Gigaceuticals AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 113. Gigaceuticals Key News & Latest Developments
Table 114. Chemical.AI Company Summary
Table 115. Chemical.AI AI Pharma Product Offerings
Table 116. Chemical.AI AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 117. Chemical.AI Key News & Latest Developments
Table 118. Artivila Company Summary
Table 119. Artivila AI Pharma Product Offerings
Table 120. Artivila AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 121. Artivila Key News & Latest Developments
Table 122. Galixir Company Summary
Table 123. Galixir AI Pharma Product Offerings
Table 124. Galixir AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 125. Galixir Key News & Latest Developments
Table 126. Xbiome Company Summary
Table 127. Xbiome AI Pharma Product Offerings
Table 128. Xbiome AI Pharma Revenue (US$, Mn) & (2018-2023)
Table 129. Xbiome Key News & Latest Developments
List of Figures
Figure 1. AI Pharma Segment by Type in 2022
Figure 2. AI Pharma Segment by Application in 2022
Figure 3. Global AI Pharma Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global AI Pharma Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global AI Pharma Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by AI Pharma Revenue in 2022
Figure 8. By Type - Global AI Pharma Revenue Market Share, 2018-2030
Figure 9. By Application - Global AI Pharma Revenue Market Share, 2018-2030
Figure 10. By Type - Global AI Pharma Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global AI Pharma Revenue Market Share, 2018-2030
Figure 12. By Application - Global AI Pharma Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global AI Pharma Revenue Market Share, 2018-2030
Figure 14. By Region - Global AI Pharma Revenue Market Share, 2018-2030
Figure 15. By Country - North America AI Pharma Revenue Market Share, 2018-2030
Figure 16. US AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 17. Canada AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe AI Pharma Revenue Market Share, 2018-2030
Figure 20. Germany AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 21. France AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 23. Italy AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 24. Russia AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia AI Pharma Revenue Market Share, 2018-2030
Figure 28. China AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 29. Japan AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 32. India AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America AI Pharma Revenue Market Share, 2018-2030
Figure 34. Brazil AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa AI Pharma Revenue Market Share, 2018-2030
Figure 37. Turkey AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 38. Israel AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 40. UAE AI Pharma Revenue, (US$, Mn), 2018-2030
Figure 41. Recursion AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Insilico Medicine AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Exscientia AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. BenevolentAI AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Atomwise AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Roivant Sciences AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Schr?dinger AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Lantern Pharma AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. XtalPi AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Landos Biopharma AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Relay Therapeutics AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Accutar Biotech AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Deep Genomics AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Oncocross AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. AI Therapeutics AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. BioMap AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. METiS Pharmaceuticals AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. NeoX Biotech AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. StoneWise AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Deep Intelligent Pharma AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Gigaceuticals AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Chemical.AI AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Artivila AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Galixir AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Xbiome AI Pharma Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
